Myalept
Active substance: metreleptin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · METRELEPTIN 11.3 mg/2.2mL
United StatesActive
Marketing holder: Chiesi USA, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- METRELEPTIN · 11.3 mg/2.2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-7f39-7d33-bbef-9790a8a77f18;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 10122-210
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 10122-210 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 10122-210 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 10122-210 · Verified 2026-10-09 · open in source